BioLineRx Ltd. financial data

Symbol
BLRX on Nasdaq
Location
Modi In
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 31 Mar 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.23B shares

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 2.23M USD -26%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 38.9M USD -39.1%
Liabilities 25.4M USD -49.8%